Ossiam’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4K | Hold |
208
| – | – | ﹤0.01% | 624 |
|
|
2025
Q1 | $14.7K | Sell |
208
-268
| -56% | -$18.9K | ﹤0.01% | 599 |
|
|
2024
Q4 | $31.3K | Sell |
476
-2,369
| -83% | -$156K | ﹤0.01% | 590 |
|
|
2024
Q3 | $200K | Sell |
2,845
-121
| -4% | -$8.51K | ﹤0.01% | 538 |
|
|
2024
Q2 | $244K | Buy |
2,966
+5
| +0.2% | +$412 | ﹤0.01% | 524 |
|
|
2024
Q1 | $259K | Sell |
2,961
-1,704
| -37% | -$149K | ﹤0.01% | 555 |
|
|
2023
Q4 | $450K | Buy |
4,665
+1,946
| +72% | +$188K | 0.01% | 488 |
|
|
2023
Q3 | $241K | Sell |
2,719
-52
| -2% | -$4.6K | ﹤0.01% | 586 |
|
|
2023
Q2 | $240K | Buy |
2,771
+1,287
| +87% | +$112K | ﹤0.01% | 577 |
|
|
2023
Q1 | $144K | Sell |
1,484
-5,597
| -79% | -$544K | ﹤0.01% | 531 |
|
|
2022
Q4 | $733K | Buy |
7,081
+2,620
| +59% | +$271K | 0.02% | 314 |
|
|
2022
Q3 | $378K | Sell |
4,461
-1,302
| -23% | -$110K | 0.01% | 388 |
|
|
2022
Q2 | $478K | Buy |
5,763
+1,559
| +37% | +$129K | 0.01% | 317 |
|
|
2022
Q1 | $324K | Buy |
4,204
+1,866
| +80% | +$144K | 0.01% | 344 |
|
|
2021
Q4 | $207K | Sell |
2,338
-719
| -24% | -$63.7K | 0.01% | 365 |
|
|
2021
Q3 | $236K | Hold |
3,057
| – | – | 0.01% | 371 |
|
|
2021
Q2 | $235K | Buy |
3,057
+1,588
| +108% | +$122K | 0.01% | 371 |
|
|
2021
Q1 | $111K | Buy |
1,469
+726
| +98% | +$54.9K | ﹤0.01% | 381 |
|
|
2020
Q4 | $65K | Buy |
743
+624
| +524% | +$54.6K | ﹤0.01% | 376 |
|
|
2020
Q3 | $9K | Sell |
119
-2,016
| -94% | -$152K | ﹤0.01% | 385 |
|
|
2020
Q2 | $263K | Sell |
2,135
-9,493
| -82% | -$1.17M | 0.02% | 291 |
|
|
2020
Q1 | $983K | Buy |
11,628
+9,780
| +529% | +$827K | 0.07% | 176 |
|
|
2019
Q4 | $156K | Buy |
1,848
+1,626
| +732% | +$137K | 0.01% | 338 |
|
|
2019
Q3 | $15K | Sell |
222
-556
| -71% | -$37.6K | ﹤0.01% | 462 |
|
|
2019
Q2 | $67K | Buy |
+778
| New | +$67K | 0.01% | 399 |
|